Log in to access your PharmaMiles
and download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Holder | DMF No. | Subject | Submission Date | Status | Type | GDUFA DMF Review | GDUFA Review Date | GDUFA Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 28/08/2025 | Cipla |
India |
CIPLA LTD | 37940 | RILPIVIRINE | 2023-03-16 | Active | II | N/A | ||
| 28/08/2025 | Johnson & Johnson Innovative Medicine |
U.S.A |
JANSSEN PHARMACEUTICA NV | 33713 | RILPIVIRINE DRUG SUBSTANCE | 2019-04-22 | Active | II | N/A |
